$CELC
Celcuity Inc

2021 Q1 Form 10-Q Financial Statement

#000165495421005361 Filed on May 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $560.0K $440.0K $460.0K
YoY Change 21.74% 10.0% 21.05%
% of Gross Profit
Research & Development $2.236M $2.110M $1.847M
YoY Change 21.05% 40.67% 16.12%
% of Gross Profit
Depreciation & Amortization $98.22K $100.0K $94.79K
YoY Change 3.62% 11.11% 24.45%
% of Gross Profit
Operating Expenses $2.792M $2.550M $2.311M
YoY Change 20.81% 34.21% 17.03%
Operating Profit -$2.792M -$2.311M
YoY Change 20.81% 17.03%
Interest Expense $24.00 $0.00 $33.00
YoY Change -27.27% -100.0% -23.26%
% of Operating Profit
Other Income/Expense, Net $101.00 $63.82K
YoY Change -99.84% -50.37%
Pretax Income -$2.792M -$2.550M -$2.247M
YoY Change 24.24% 40.88% 21.73%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.792M -$2.550M -$2.247M
YoY Change 24.24% 40.88% 21.73%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$252.0K -$248.1K -$219.5K
COMMON SHARES
Basic Shares Outstanding 10.30M shares 10.30M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.94M $11.64M $16.85M
YoY Change 107.36% -37.89% -28.05%
Cash & Equivalents $34.94M $11.64M $16.85M
Short-Term Investments
Other Short-Term Assets $590.0K $340.0K $400.0K
YoY Change 47.5% 6.25% 17.65%
Inventory
Prepaid Expenses $551.3K $317.0K
Receivables
Other Receivables $190.0K $190.0K
Total Short-Term Assets $35.71M $12.17M $17.44M
YoY Change 104.78% -36.8% -26.61%
LONG-TERM ASSETS
Property, Plant & Equipment $466.5K $558.9K $950.0K
YoY Change -50.9% -32.95% 10.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $653.1K $789.8K $950.0K
YoY Change -31.25% -23.35% -19.35%
TOTAL ASSETS
Total Short-Term Assets $35.71M $12.17M $17.44M
Total Long-Term Assets $653.1K $789.8K $950.0K
Total Assets $36.37M $12.96M $18.39M
YoY Change 97.75% -36.11% -26.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $318.2K $217.4K $70.00K
YoY Change 354.59% 52.25% -66.49%
Accrued Expenses $660.8K $774.6K $790.0K
YoY Change -16.35% 32.57% 62.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $1.171M $1.185M $860.0K
YoY Change 36.11% 30.06% -2.51%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% -50.0%
Other Long-Term Liabilities $20.00K $60.00K $0.00
YoY Change 0.0% -100.0%
Total Long-Term Liabilities $30.00K $70.00K $10.00K
YoY Change 200.0% 0.0% -95.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.171M $1.185M $860.0K
Total Long-Term Liabilities $30.00K $70.00K $10.00K
Total Liabilities $1.193M $1.254M $880.0K
YoY Change 35.51% 27.59% -18.31%
SHAREHOLDERS EQUITY
Retained Earnings -$29.11M -$26.32M
YoY Change 56.24%
Common Stock $12.29K $10.30K
YoY Change 0.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.17M $11.70M $17.52M
YoY Change
Total Liabilities & Shareholders Equity $36.37M $12.96M $18.39M
YoY Change 97.75% -36.11% -26.26%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q1
OPERATING ACTIVITIES
Net Income -$2.792M -$2.550M -$2.247M
YoY Change 24.24% 40.88% 21.73%
Depreciation, Depletion And Amortization $98.22K $100.0K $94.79K
YoY Change 3.62% 11.11% 24.45%
Cash From Operating Activities -$2.522M -$2.110M -$1.834M
YoY Change 37.52% 23.39% 15.32%
INVESTING ACTIVITIES
Capital Expenditures $30.93K -$10.00K $45.60K
YoY Change -32.19% -66.67% -4.28%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$30.43K -$10.00K -$45.60K
YoY Change -33.28% -100.24% -123.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $25.85M 60.00K -$1.438K
YoY Change -1797799.65% 100.0% -100.83%
NET CHANGE
Cash From Operating Activities -$2.522M -2.110M -$1.834M
Cash From Investing Activities -$30.43K -10.00K -$45.60K
Cash From Financing Activities $25.85M 60.00K -$1.438K
Net Change In Cash $23.30M -2.060M -$1.881M
YoY Change -1338.88% -183.74% 54.1%
FREE CASH FLOW
Cash From Operating Activities -$2.522M -$2.110M -$1.834M
Capital Expenditures $30.93K -$10.00K $45.60K
Free Cash Flow -$2.552M -$2.100M -$1.879M
YoY Change 35.82% 25.0% 14.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12647037 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34936902 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11637911 USD
CY2021Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
22009 USD
CY2020Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
22009 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38013551 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29113249 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26321581 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
35174544 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11702270 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36367061 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12956747 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2236342 USD
CY2021Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
13719 USD
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
0 USD
CY2021Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
190000 USD
CY2020Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
190000 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
551345 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
317040 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
35713975 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
12166960 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
466484 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
558876 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
186602 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
230911 USD
CY2021Q1 us-gaap Assets
Assets
36367061 USD
CY2020Q4 us-gaap Assets
Assets
12956747 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
318213 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
217377 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5819 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
5810 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
185656 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
187518 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
660849 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
774612 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1170537 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1185317 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6841 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
8299 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15139 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60861 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1192517 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1254477 USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12287896 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10299822 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
12288 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
10300 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64275505 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1847414 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
555428 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
463399 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2791770 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
2310813 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2791770 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2310813 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
24 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45604 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
33 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
388 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
63851 USD
CY2021Q1 celc Loss On Sale Of Fixed Assets
LossOnSaleOfFixedAssets
263 USD
CY2020Q1 celc Loss On Sale Of Fixed Assets
LossOnSaleOfFixedAssets
0 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
101 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63818 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2791668 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2246995 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2791668 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2246995 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11072097 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10253988 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11702270 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
449098 USD
CY2021Q1 celc Exercise Of Common Stock Warrants Amount
ExerciseOfCommonStockWarrantsAmount
11257 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25768493 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38962 USD
CY2021Q1 celc Issuance Costs Associated With Atm Offering
IssuanceCostsAssociatedWithAtmOffering
-3868 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2791668 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
35174544 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
19297571 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
464649 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2246995 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
17515225 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2791668 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2246995 USD
CY2021Q1 us-gaap Depreciation
Depreciation
98222 USD
CY2020Q1 us-gaap Depreciation
Depreciation
94792 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
449098 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
464649 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
263 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-234305 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-62651 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
73924 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-92197 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-113763 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
30143 USD
CY2021Q1 celc Increase Decrease In Non Cash Operating Lease Expense
IncreaseDecreaseInNonCashOperatingLeaseExpense
-3276 USD
CY2020Q1 celc Increase Decrease In Non Cash Operating Lease Expense
IncreaseDecreaseInNonCashOperatingLeaseExpense
-21342 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2521505 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1833601 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30925 USD
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
500 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30425 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45604 USD
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11257 USD
CY2020Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2021Q1 celc Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
25814167 USD
CY2020Q1 celc Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
0 USD
CY2021Q1 celc Gross Proceeds From An Atm Offering
GrossProceedsFromAnAtmOffering
38962 USD
CY2020Q1 celc Gross Proceeds From An Atm Offering
GrossProceedsFromAnAtmOffering
0 USD
CY2021Q1 celc Payments For Registration Statement Costs
PaymentsForRegistrationStatementCosts
12016 USD
CY2020Q1 celc Payments For Registration Statement Costs
PaymentsForRegistrationStatementCosts
0 USD
CY2021Q1 celc Payments For Finance Leases
PaymentsForFinanceLeases
1449 USD
CY2020Q1 celc Payments For Finance Leases
PaymentsForFinanceLeases
1438 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25850921 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1438 USD
CY2021Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
23298991 USD
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1880643 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11637911 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18735002 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34936902 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16854359 USD
CY2021Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
CY2020Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
14101 USD
CY2021Q1 celc Offering And Registration Statement Costs Included In Accounts Payable
OfferingAndRegistrationStatementCostsIncludedInAccountsPayable
51245 USD
CY2020Q1 celc Offering And Registration Statement Costs Included In Accounts Payable
OfferingAndRegistrationStatementCostsIncludedInAccountsPayable
6127 USD
CY2021Q1 celc Issuance Of Common Stock Upon Closing Of Follow On Offering Net Shares
IssuanceOfCommonStockUponClosingOfFollowOnOfferingNetShares
1971100 shares
CY2021Q1 celc Issuanceofcommonstockuponclosingoffollowonofferingincludingsharesofcommon Stock
IssuanceofcommonstockuponclosingoffollowonofferingincludingsharesofcommonStock
257100 shares
CY2021Q1 us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
14.00
CY2021Q1 celc Net Of Underwriting Discounts And Offering Costs
NetOfUnderwritingDiscountsAndOfferingCosts
27600000 USD
CY2021Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
1600000 USD
CY2021Q1 celc Offering Expenses
OfferingExpenses
200000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Management uses estimates and assumptions in preparing these unaudited condensed financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from those estimates and the difference could be material. Significant items subject to such estimates and assumptions include the valuation of stock-based compensation and prepaid or accrued clinical trial costs.</p>
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;font-family:times new roman;margin:0px">The Company is subject to risks common to companies in the development stage including, but not limited to, dependency on the clinical and commercial success of its diagnostic tests, ability to obtain regulatory approval of its diagnostic tests, the clinical and commercial success of its initial drug product, gedatolisib, the need for substantial additional financing to achieve its goals, uncertainty of broad adoption of its approved products, if any, by physicians and consumers, and significant competition.</p>
CY2021Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
197211 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
27600000 USD
CY2021Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
1600000 USD
CY2021Q1 celc Offering Expenses
OfferingExpenses
200000 USD
CY2021Q1 celc Operating Lease Weighted Average Remaining Leases Term1
OperatingLeaseWeightedAverageRemainingLeasesTerm1
P1Y1M6D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040 pure
CY2021Q1 celc Finance Lease Weighted Average Remaining Leases Term1
FinanceLeaseWeightedAverageRemainingLeasesTerm1
P2Y1M6D
CY2021Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.010 pure
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
45430 USD
CY2021Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1447 USD
CY2021Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
24 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
19869 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
66770 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
68574 USD
CY2021Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
24 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1449 USD
CY2021Q1 celc Cash Paid For Operating And Finance Leases
CashPaidForOperatingAndFinanceLeases
70047 USD
CY2021Q1 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
275000 USD
CY2020 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
100000 USD
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
600000 USD
CY2021Q1 celc Estimated Remaining Amount Of Payments
EstimatedRemainingAmountOfPayments
2340000 USD
CY2021Q1 celc Issuance Of Common Stock Upon Closing Of Follow On Offering Net Shares
IssuanceOfCommonStockUponClosingOfFollowOnOfferingNetShares
1971100 shares
CY2021Q1 celc Issuanceofcommonstockuponclosingoffollowonofferingincludingsharesofcommon Stock
IssuanceofcommonstockuponclosingoffollowonofferingincludingsharesofcommonStock
257100 shares
CY2021Q1 celc Public Offering Price
PublicOfferingPrice
14.00
CY2021Q1 celc Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Remainder Of Fiscal Year
EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear
1032220 USD
CY2021Q1 celc Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Within Two Years
EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedWithinTwoYears
1147153 USD
CY2021Q1 celc Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Within Three Years
EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedWithinThreeYears
789853 USD
CY2021Q1 celc Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Within Four Years
EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedWithinFourYears
291273 USD
CY2021Q1 celc Employee Service Share Based Compensation Non Vested Awards Compensation Cost Not Yet Recognized Within Five Years
EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedWithinFiveYears
11616 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3272115 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
449098 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
464649 USD

Files In Submission

Name View Source Status
0001654954-21-005361-index-headers.html Edgar Link pending
0001654954-21-005361-index.html Edgar Link pending
0001654954-21-005361.txt Edgar Link pending
0001654954-21-005361-xbrl.zip Edgar Link pending
celc-20210331.xsd Edgar Link pending
celc-20210331_cal.xml Edgar Link unprocessable
celc-20210331_def.xml Edgar Link unprocessable
celc-20210331_lab.xml Edgar Link unprocessable
celc-20210331_pre.xml Edgar Link unprocessable
celc_10q.htm Edgar Link pending
celc_10qimg10.jpg Edgar Link pending
celc_10qimg11.jpg Edgar Link pending
celc_10qimg12.jpg Edgar Link pending
celc_10qimg7.jpg Edgar Link pending
celc_10qimg8.jpg Edgar Link pending
celc_10qimg9.jpg Edgar Link pending
celc_10q_htm.xml Edgar Link completed
celc_ex311.htm Edgar Link pending
celc_ex312.htm Edgar Link pending
celc_ex321.htm Edgar Link pending
celc_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending